Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Whole lung irradiation, used to treat pulmonary metastases of solid malignancies in children, can lead to increasing pulmonary problems, Tennessee-based researchers report in…
NEW YORK (Reuters Health) – Most patients with differentiated thyroid cancer metastasized to bone benefit from iodine-131 therapy, with stabilization of disease and significant reduction in pain, a…
NEW YORK (Reuters Health) – Combining an EGFR-directed tyrosine kinase inhibitor with conventional chemotherapy does not seem to be a good treatment strategy for lung cancer. According to…
NEW YORK (Reuters Health) – Pooled data suggest that cancer patients who are treated with sunitinib (Sutent; Pfizer) have about a 2-fold increased relative risk of developing high-grade…
NEW YORK (Reuters Health) – Nearly 1 in 5 cancer patients treated with cisplatin-based chemotherapy have a thromboembolic event within a month of ending treatment, according to a…
NEW YORK (Reuters Health) – Results of two phase II trials investigating the addition of bortezomib to combination treatments of follicular lymphoma suggest that the strategy is feasible…
NEW YORK (Reuters Health) – Radiofrequency ablation (RFA) is a viable alternative in patients with early hepatocellular carcinoma who are not candidates for surgery, Taiwanese researchers report in…
NEW YORK (Reuters Health) – Pneumothorax occurs in 15% of patients having a transthoracic needle biopsy of a pulmonary nodule, according to the findings of a population-based cross-sectional…
NEW YORK (Reuters Health) – When added to whole-brain irradiation, radiosurgery is preferable to neurosurgical resection for treating cancer patients with a single metastasis to the brain, according…
NEW YORK (Reuters Health) – Epoetin alpha can reduce the number of erythrocyte transfusions needed in patients with acute leukemia undergoing myelosuppressive chemotherapy, without affecting length of remission,…
